Source: Gen9 Blog

Gen9 Blog How Synthetic DNA Can Help Combat Antibiotic Resistance

Antibiotic resistance is a growing problem in our world. Devin Leake, Vice President of Research and Development at Gen9, weighs in on how synthetic biology--and specifically long-length synthetic DNA constructs--can combat the issue of antibiotic resistance.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kevin Munnelly's photo - President & CEO of Gen9

President & CEO

Kevin Munnelly

CEO Approval Rating

63/100

Read more